|
MCID: MCP001
|
Mucopolysaccharidosis Iii malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Mucopolysaccharidosis type III (MPS III) is a genetic disorder that makes the body unable to break down large sugar molecules called glycosaminoglycans (GAGs, formerly called mucopolysaccharides). Specifically, people with this condition are unable to break down a GAG called heparan sulfate. Affected individuals can have severe neurological symptoms, including progressive dementia, aggressive behavior, hyperactivity, seizures, deafness, loss of vision, and an inability to sleep for more than a few hours at a time. MPS III is inherited in an autosomal recessive manner. There is no specific treatment for this condition. Most people with MPS III live into their teenage years, and some live longer. MPS III is divided into four subtypes, known as A, B, C and D. Each subtype is caused by the alteration of a different enzyme needed to completely break down heparan sulfate. The different types of MPS III have similar signs and symptoms, although type A is the most severe. To view the GARD pages on the subtypes of MPS III, click on the following links:
Mucopolysaccharidosis type IIIA Mucopolysaccharidosis type IIIB Mucopolysaccharidosis type IIIC Mucopolysaccharidosis type IIID30
MalaCards: Mucopolysaccharidosis Iii, also known as mucopolysaccharidosis type iiia, is related to mucopolysaccharidosis and lysosomal storage disease. An important gene associated with Mucopolysaccharidosis Iii is SGSH (N-sulfoglucosamine sulfohydrolase), and among its related pathways are Glycosaminoglycan degradation and MPS IIIC - Sanfilippo syndrome C. The compounds lithium and glycosaminoglycan have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and b cells. Genetics Home Reference: Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that mainly affects the brain and spinal cord (central nervous system).17 Wikipedia: Sanfilippo syndrome, or Mucopolysaccharidosis III (MPS-III) is a rare autosomal recessive lysosomal...44 more... |
|
Sources: 6Disease Ontology, 8DISEASES, 43UMLS, 30NIH Rare Diseases, 16GeneTests, 17Genetics Home Reference, 7diseasecard, 32Novoseek , 40SNOMED-CT, 24MeSH, 33OMIM, 27NCIt See all sources |
Aliases & Descriptions:
|
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for mucopolysaccharidosis iii Drug clinical trials:Search ClinicalTrials for mucopolysaccharidosis iii Search NIH Clinical Center for mucopolysaccharidosis iii Search CenterWatch for mucopolysaccharidosis iii |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to mucopolysaccharidosis iii:22Brain, Spinal cord, B cells
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to mucopolysaccharidosis iii:
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 20KEGG, 38Reactome See all sources |
|
Sources: 32Novoseek , 34PharmGKB, 9DrugBank, 18HMDB See all sources |
|
Sources: 12Gene Ontology See all sources |
Cellular components related to mucopolysaccharidosis iii according to GeneDecks:
Biological processes related to mucopolysaccharidosis iii according to GeneDecks:
|
